患有阿尔茨海默病的非英语发言者的连接语音特征:范围评估审查的协议
Arpita Bose1, Samrah Ahmed2,3, Yesi Cheng2,4
1School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK. a.bose@reading.ac.uk.
Systematic reviews
|January 25, 2024
概括
本综述考察了阿尔茨海默病 (AD) 的连接语音,跨越非英语语言. 它突出了语言的变化,并为各种人群的未来研究提供了信息.
科学领域:
- 神经语言学是一种神经语言学.
- 计算语言学 计算语言学
- 临床语言学 临床语言学
背景情况:
- 连接语音分析对于阿尔茨海默病 (AD) 的诊断和监测至关重要.
- 现有的研究主要集中在英语上,限制了对AD语言多样性的洞察力.
- 需要了解AD如何影响各种语言的言语.
研究的目的:
- 审查阿尔茨海默病 (AD) 患者的连接语音特征,说非英语语言.
- 识别用于AD语音研究的评估方法,语音诱导技术和语言框架.
- 绘制非英语口语AD人群中言语的微观和宏观语言特征.
主要方法:
- 关于阿尔茨海默病患者连接言语的定量研究的范围审查.
- 纳入标准:阿尔茨海默病 (AD) 的临床诊断.
- 在主要数据库 (PubMed,Embase,PsycINFO,LLBA,Web of Science) 进行的搜索截至2023年3月.
主要成果:
- 在AD的非英语连接语音研究中研究的语言概述.
- 分析方法,包括患者特征和语音采样技术.
- 在AD语音中识别报告的微观和宏观语言特征.
结论:
- 该审查提供了关于AD在不同语言中连接语音的语言变异的见解.
- 结果将指导未来的研究,促进语言多样性人口的包容性.
- 增强对AD对英语发言者以外的沟通影响的理解.
相关概念视频
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193


